Crescent Grove Advisors’s Lantheus LNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Sell
16,907
-4,166
-20% -$299K 0.12% 123
2025
Q4
$1.4M Hold
21,073
0.13% 103
2025
Q3
$1.08M Hold
21,073
0.1% 115
2025
Q2
$1.73M Sell
21,073
-1,300
-6% -$114K 0.17% 85
2025
Q1
$2.18M Sell
22,373
-2,989
-12% -$280K 0.23% 72
2024
Q4
$2.27M Hold
25,362
0.22% 73
2024
Q3
$2.78M Hold
25,362
0.28% 60
2024
Q2
$2.04M Sell
25,362
-8,692
-26% -$638K 0.22% 70
2024
Q1
$2.12M Hold
34,054
0.22% 68
2023
Q4
$2.11M Sell
34,054
-4,294
-11% -$291K 0.24% 66
2023
Q3
$2.66M Hold
38,348
0.33% 52
2023
Q2
$3.22M Hold
38,348
0.35% 54
2023
Q1
$3.17M Hold
38,348
0.37% 49
2022
Q4
$1.95M Hold
38,348
0.2% 71
2022
Q3
$2.7M Hold
38,348
0.31% 46
2022
Q2
$2.53M Hold
38,348
0.27% 50
2022
Q1
$2.12M Hold
38,348
0.21% 57
2021
Q4
$1.11M Sell
38,348
-3,450
-8% -$91.8K 0.1% 105
2021
Q3
$1.07M Sell
41,798
-10,000
-19% -$261K 0.11% 98
2021
Q2
$1.43M Buy
+51,798
New +$1.19M 0.15% 78

Other funds holding LNTH

Crescent Grove Advisors's LNTH Position: Q1 2026 in Review

Crescent Grove Advisors reduced its Lantheus (LNTH) stake by 20% in Q1 2026, selling an estimated $299K and leaving 16,907 shares worth $1.28M. The position accounts for 0.12% of the portfolio, ranked #123.

Crescent Grove Advisors first reported a position in LNTH in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.22M in Q2 2023. 404 funds tracked by Wall St. Rank hold LNTH as of Q1 2026.

  • Crescent Grove Advisors held 16,907 shares of Lantheus worth $1.28M as of Q1 2026.
  • Crescent Grove Advisors sold 4,166 Lantheus shares in Q1 2026, an estimated $299K.
  • Lantheus made up 0.12% of Crescent Grove Advisors's portfolio in Q1 2026, its #123 holding.
  • Crescent Grove Advisors first reported a position in Lantheus in Q2 2021 and has held it in 20 quarters since.
  • Crescent Grove Advisors's Lantheus position peaked at $3.22M in Q2 2023.
  • 404 funds tracked by Wall St. Rank held Lantheus as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.